Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models()...

Por Ponte, Jose F., Ab, Olga, Lanieri, Leanne, Lee, Jenny, Coccia, Jennifer, Bartle, Laura M., Themeles, Marian, Zhou, Yinghui, Pinkas, Jan, Ruiz-Soto, Rodrigo
Publicado no Neoplasia (2016)

Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody–Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Per...

Por Moore, Kathleen N., Martin, Lainie P., O’Malley, David M., Matulonis, Ursula A., Konner, Jason A., Perez, Raymond P., Bauer, Todd M., Ruiz-Soto, Rodrigo, Birrer, Michael J.
Publicado no J Clin Oncol (2017)

Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the F...

Por Martin, Lainie P., Konner, Jason A., Moore, Kathleen N., Seward, Shelly M., Matulonis, Ursula A., Perez, Raymond P., Su, Ying, Berkenblit, Anna, Ruiz-Soto, Rodrigo, Birrer, Michael J.
Publicado no Gynecol Oncol (2017)

ACTR-02. DCC-2618, A NOVEL pan-KIT AND PDGFRa KINASE SWITCH CONTROL INHIBITOR, SHOWS ENCOURAGING SIGNAL IN A PATIENT (PT) WITH GLIOBLASTOMA (GBM)

Por de Groot, John, George, Suzanne, Razak, Albiruni, Gordon, Michael, Janku, Filip, Ligon, Keith, Wen, Patrick, Friedlander, Sharon, Flynn, Daniel, Kaufman, Michael, Pitman, Jama, Ruiz-Soto, Rodrigo, Smith, Bryan, Westwood, Deborah, Rosen, Oliver, Reardon, David
Publicado no Neuro Oncol (2017)

Phase 1 Dose-Escalation Study of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor α-Targeting Antibody-Drug Conjugate, in Patients With Solid Tumors

Por Moore, Kathleen N., Borghaei, Hossein, O’Malley, David M., Jeong, Woondong, Seward, Shelly M., Bauer, Todd M., Perez, Raymond P., Matulonis, Ursula A., Running, Kelli L., Zhang, Xiaoyan, Ponte, Jose F., Ruiz-Soto, Rodrigo, Birrer, Michael J.
Publicado no Cancer (2017)

Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib

Por Janku, Filip, Abdul Razak, Albiruni R., Chi, Ping, Heinrich, Michael C., von Mehren, Margaret, Jones, Robin L., Ganjoo, Kristen, Trent, Jonathan, Gelderblom, Hans, Somaiah, Neeta, Hu, Simin, Rosen, Oliver, Su, Ying, Ruiz-Soto, Rodrigo, Gordon, Michael, George, Suzanne
Publicado no J Clin Oncol (2020)